Published: May 07, 2021
May 7, 2021 04:00 UTC
Pamiparib becomes the first PARP inhibitor approved in both platinum-sensitive and platinum-resistant relapsed ovarian cancer in China
This marks the first approval of pamiparib and the third BeiGene-discovered medicine to receive regulatory approval
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that its PARP inhibitor pamiparib has received conditional approval from the China National Medical Products Administration (NMPA) for the treatment of patients with germline
BRCA (
gBRCA) mutation-associated recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer who have been treated with two or more lines of chemotherapy. The new drug application was previously granted priority review by the Center for Drug Evaluation (CDE) in July 2020. BeiGene is preparing to launch pamiparib this month.
China NMPA Approves PARP Inhibitor Pamiparib for Patients with Previously Treated Advanced Ovarian Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Mount Vernon News
mountvernonnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mountvernonnews.com Daily Mail and Mail on Sunday newspapers.
The Citizen
your username
your email
Password recovery
A Survivors Story and her “HART” to help other women.
The mission of “Harts of Teal” is to celebrate victories, honor memories, empower women, educate the community and raise funds for diagnostic research for Ovarian Cancer and similar gynecologic cancers. My name is Kimberly Airhart. I am a recent ovarian cancer survivor, wife, and mother to five wonderful children. In February 2020 I was diagnosed with Stage 3C Ovarian Cancer. Healthy, active, and barely over 40, ovarian cancer was the last thing on my mind. Life as I knew it changed forever. Chemotherapy, major surgery, and maintenance drugs became my new way of life…but…my story allowed me to connect with others on the same journey. Through this experience, I started to understand the importance of early detection and community awareness.